Rafferty Eamon P, Wylie Alastair R, Elliott Chris T, Chevallier Olivier P, Grieve David J, Green Brian D
School of Biological Sciences, Queen's University Belfast, BT9 5AG, Northern Ireland, United Kingdom.
Sci Pharm. 2011 Jul-Sep;79(3):615-21. doi: 10.3797/scipharm.1104-16. Epub 2011 Jun 9.
Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS), beta casein (BCAS) and chlorogenic acid (CGA) were assessed in STC-1 cells and C57BL/6 mice. All compounds except ACAS significantly increased acute in vitro GLP-1 secretion (66-386%; P<0.05-0.001). Oral gavage of OLE and GLN modestly increased plasma GLP-1 concentrations (48% and 41%, respectively), but did not lower glycaemic excursions. OLE and GLN are potent stimulators of GLP-1 secretion both in vitro and in vivo and chronic studies should assess their suitability as nutritional therapies for type 2 diabetes.
胰高血糖素样肽-1(GLP-1)是一种具有公认降糖活性的肠道激素。对GLP-1天然假定促分泌剂的体外和体内作用进行了研究。在STC-1细胞和C57BL/6小鼠中评估了橄榄叶提取物(OLE)、谷氨酰胺(GLN)、α-酪蛋白(ACAS)、β-酪蛋白(BCAS)和绿原酸(CGA)的急性GLP-1释放活性。除ACAS外,所有化合物均显著增加体外急性GLP-1分泌(66%-386%;P<0.05-0.001)。经口灌胃给予OLE和GLN适度增加血浆GLP-1浓度(分别为48%和41%),但并未降低血糖波动。OLE和GLN在体外和体内均是GLP-1分泌的有效刺激剂,长期研究应评估它们作为2型糖尿病营养疗法的适用性。